Dr. Michael Guarino, MD
Claim this profileChristiana Hospital
Studies Pancreatic Cancer
Studies Hemangiopericytoma
4 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Michael Guarino, MD is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
More about Michael Guarino, MD
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael Guarino, MD has experience with
- APL-101
- Glufosfamide
- Fluorouracil
- Pembrolizumab
- Ladiratuzumab Vedotin
- Radium-223
Breakdown of trials Michael Guarino, MD has run
Hemangiopericytoma
Methylation Alteration
MET Fusion
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Guarino, MD specialize in?
Michael Guarino, MD focuses on Pancreatic Cancer and Hemangiopericytoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Michael Guarino, MD currently recruiting for clinical trials?
Yes, Michael Guarino, MD is currently recruiting for 3 clinical trials in Newark Delaware. If you're interested in participating, you should apply.
Are there any treatments that Michael Guarino, MD has studied deeply?
Yes, Michael Guarino, MD has studied treatments such as APL-101, Glufosfamide, Fluorouracil.
What is the best way to schedule an appointment with Michael Guarino, MD?
Apply for one of the trials that Michael Guarino, MD is conducting.
What is the office address of Michael Guarino, MD?
The office of Michael Guarino, MD is located at: Christiana Hospital, Newark, Delaware 19713 United States. This is the address for their practice at the Christiana Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.